Revelation Partners


Revelation Partners is a healthcare-focused private investment firm that provides growth capital and customized liquidity solutions to healthcare companies, shareholders and fund managers. The firm sources growth equity, purchases or provides liquidity for existing shareholders (founders, employees, investors), and structures GP-led and fund-level solutions such as continuation funds and restructurings. Revelation positions itself as a specialist partner across medical devices, diagnostics, healthcare technology and services, and biotherapeutics.

Revelation Partners

San Francisco, California, United States, North America


Services

Growth capital

Provides primary growth equity or follow-on capital to revenue-stage and scaling healthcare companies to accelerate commercialization and growth initiatives.

Shareholder liquidity (direct secondaries)

Structured purchases of shares from founders, early employees, angel investors and institutional shareholders to provide personal or investor liquidity without requiring a full company exit.

Fund manager solutions (GP-led & fund-level liquidity)

Customized solutions for general partners and limited partners including GP-led continuation vehicles, fund restructurings, LP tenders, single-asset and multi-asset transactions, and purchase of fund interests.

Portfolio & operational partnership

Ongoing strategic partnership with underlying companies including board roles, reserves for follow-on financings, and operational support to pursue growth milestones.

White papers, webinars and education for stakeholders

Research and educational material on secondaries, GP-led restructurings, and liquidity options for healthcare companies and fund managers.


Portfolio

Revelation acquired common shares from early employees to provide personal liquidity; Iris provides telepsychiatry services across inpatient settings, community mental health centers, community health centers, health systems and hospitals.

#Telepsychiatry / mental health services

Provided liquidity to a mix of early preferred and common shareholders and invested in a $25 million financing to accelerate commercialization and R&D.

#Metabolomics / diagnostic and research services

Revelation acted as a strategic capital partner providing liquidity to existing shareholders and growth capital to scale remote patient monitoring solutions.

#Wearable biosensors / remote patient monitoring

Revelation referenced as a backer in company news about Omada's IPO and commercial partnerships.

#Digital health / virtual care and behavior change programs

Site lists Click Therapeutics among active portfolio news; announcement relates to FDA marketing authorization for CT-132.

#Digital therapeutics / prescription digital therapeutic

Revelation referenced in news describing expansion and company model in interventional spine care.

#Medtech / interventional spine care

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.